Statin-induced lung injury: Diagnostic clue and outcome

Postgraduate Medical Journal

Volumn 89, Issue 1047, 2013, Pages 14-19

  Huang, Li Kuo ^a   Tsai, Ming Ji ^a   Tsai, Han Chen ^a   Chao, Heng Sheng ^a,b   Lin, Fang Chi ^a,b   Chang, Shi Chuan ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; METHYLPREDNISOLONE; PREDNISOLONE; ROSUVASTATIN; SIMVASTATIN; STATIN (PROTEIN);

ADULT; AGED; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; DRUG WITHDRAWAL; DYSPNEA; FIBROSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXEMIA; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS MACROPHAGE; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG INJURY; LUNG LAVAGE; MALE; PLEURA EFFUSION; PLEURA THICKENING; SPIROMETRY;

ADULT; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LUNG; LUNG INJURY; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TAIWAN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84871610100     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2011-130209     Document Type: Article

References (23)

1. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
2. Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interact. Circulation 2004;109(Suppl 1):III50-7.
3. Farmer JA, Torre-Amione G. Comparative tolerability of the HMG-CoA reductase inhibitors. Drug Saf 2000;23:197-213.
4. Hill C, Zeitz C, Kirkham B. Dermatomyositis with lung involvement in a patient treated with simvastatin. Aust N Z J Med 1995;25:745-6.
5. De Groot RE, Willems LN, Dijkman JH. Interstitial lung disease with pleural effusion caused by simvastatin. J Intern Med 1996;239:361-3.
6. Sridhar MK, Abdulla A. Fatal lupus-like syndrome and ARDS induced by fluvastatin (letter). Lancet 1998;352:114.
7. Liebhaber MI, Wright RS, Gelberg HJ, et al. Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG-CoA reductase inhibitors: a report of ten cases. Chest 1999;115:886-9.
8. Lantuejoul S, Brambilla E, Brambilla C, et al. Statin-induced fibrotic nonspecific interstitial pneumonia. Eur Respir J 2002;19:577-80.
9. Walker T, McCaffery J, Steinfort C. Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease. MJA 2007;186:91-4.
10. Veyac G, Cellerin L, Jolliet P. A case of interstitial lung disease with atorvastatin (Tahor) and a review of the literature about these effects observed under statins. Therapie 2006;61:57-67. (In French English abstract)
11. Liscoët-Loheac N, André N, Couturaud F, et al. Hypersensitivity pneumonitis in a patient taking pravastatin (in French). Rev Mal Respir 2001;18(4 Pt 1):426-8.
12. Fernandez AB, Karas RH, Alsheikh-Ali AA, et al. Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports. Chest 2008;134:824-30.
13. Xu JF, Washko GR, Nakahira K, et al. Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am J Respir Crit Care Med 2012;185:547-56.
14. Flieder DB, Travis WD. Pathologic characteristics of drug-induced lung disease. Clin Chest Med 2004;25:37-45.
15. Costabel U, Uzaslan E, Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med 2004;25:25-35.
16. Schmitz G, Grandl M. Endolysosomal phospholipidosis and cytosolic lipid droplet storage and release in macrophages. Biochim Biophys Acta 2009;1791:524-39.
17. Israël-Biet D, Venet A, Caubarrère I, et al. Bronchoalveolar lavage in amiodarone pneumonitis: cellular abnormalities and their relevance to pathogenesis. Chest 1987;91:214-21.
18. Chang CL, Chern MS, Chang SC. Amiodarone toxicity in a patient with simultaneous involvement of cornea, thyroid gland, and lung. Am J Med Sci 2000;320:64-8.
19. Rossi SE, Erasmus JJ, McAdams HP, et al. Pulmonary drug toxicity: Radiologic and pathologic manifestations. RadioGraphics 2000;20:1245-59.
20. Cleverley JR, Screaton NJ, Hiorns MP, et al. Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol 2002;57:292-9.
21. Ryu JH, Daniels CE, Hartman TE, et al. Diagnosis of interstitial lung diseases. Mayo Clin Proc 2007;82:976-86.
22. Screaton NJ, Hiorns MP, Lee KS, et al. Serial high resolution CT in non-specific interstitial pneumonia: prognostic value of the initial pattern. Clin Radiol 2005;60:96-104.
23. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003;58:143-8.